These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9676284)

  • 21. Lessening the punch of heparin-induced thrombocytopenia.
    Maloney JP
    Chest; 2002 Jul; 122(1):5-6. PubMed ID: 12114329
    [No Abstract]   [Full Text] [Related]  

  • 22. Hirulog therapy for heparin-associated thrombocytopenia and deep venous thrombosis.
    Reid T; Alving BM
    Am J Hematol; 1994 Apr; 45(4):352-3. PubMed ID: 8192819
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment with lepirudin in heparin-induced thrombocytopenia. A case report].
    Nippert M; de Maistre E; Rodermann M; Vançon AC; Amrein D; Brembilla-Perrot B; Lecompte T; Zannad F; Aliot E
    Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1234-8. PubMed ID: 12611047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hirudins in the treatment of heparin-induced thrombocytopenia and in thrombosis prophylaxis].
    Lubenow N; Greinacher A
    Hamostaseologie; 2002 Aug; 22(3):44-54. PubMed ID: 12215761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
    Chamberlin JR; Lewis B; Leya F; Wallis D; Messmore H; Hoppensteadt D; Walenga JM; Moran S; Fareed J; McKiernan T
    Can J Cardiol; 1995 Jun; 11(6):511-4. PubMed ID: 7780873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Heparin-induced thrombocytopenia].
    Christoffersen C; Lethagen S; Gøtze JP
    Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hirudin for heparin-induced thrombopenia: a new step forward].
    Lecompte T
    Presse Med; 1998 Jun; 27 Suppl 2():3-4. PubMed ID: 9765657
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia.
    Schiele F; Vuillemenot A; Kramarz P; Kieffer Y; Anguenot T; Bernard Y; Bassand JP
    Am J Hematol; 1995 Sep; 50(1):20-5. PubMed ID: 7668220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.
    Greinacher A; Lubenow N; Eichler P
    Circulation; 2003 Oct; 108(17):2062-5. PubMed ID: 14568897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hirudin-based anticoagulant strategy during isolated limb perfusion in a patient with heparin-induced thrombocytopenia.
    Lindemann W; Richter S; Schilling MK
    Melanoma Res; 2005 Aug; 15(4):287-90. PubMed ID: 16034307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of thrombosis with subcutaneous recombinant hirudin in heparin-induced thrombocytopenia type II. A pilot study].
    Huhle G; Hoffmann U; Hoffmann I; Harenberg J; Heene DL
    Dtsch Med Wochenschr; 2000 Jun; 125(22):686-91. PubMed ID: 10874895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of an acute flush reaction caused by subcutaneous r-hirudin with pegylated hirudin.
    Harenberg J; Hoffmann U; Huhle G; Song XH; Wang LC
    Br J Haematol; 2000 Mar; 108(3):528-30. PubMed ID: 10759710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Pinto DS; Sperling RT; Tu TM; Cohen DJ; Carrozza JP
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):65-8. PubMed ID: 12508198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant hirudin for extended aortic surgery in patients with heparin-induced thrombocytopenia.
    Bauer M; Koster A; Pasic M; Weng Y; Kuppe H; Hetzer R
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):191-2. PubMed ID: 10384203
    [No Abstract]   [Full Text] [Related]  

  • 36. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of heparin-induced thrombocytopenia: a critical review.
    Hirsh J; Heddle N; Kelton JG
    Arch Intern Med; 2004 Feb; 164(4):361-9. PubMed ID: 14980986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular drug highlight: hirudin.
    Cheng-Lai A
    Heart Dis; 1999; 1(1):41-9. PubMed ID: 11720603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
    Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
    Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hirudin in heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.